Title

Immediate and antecedent causes of mortality in hospitalised Indian patients with COVID-19

Authors

BY Keerthi¹, K Saritha^2,*, Chirali Shah³, Vimala Thomas⁴ & Vikram Cheryala⁵

Affiliation

¹Department of General Medicine, Telangana Institute of Medical Sciences and Research, Gachibowli, Hyderabad, India, 500032; ²Department of Family Medicine, Telangana Institute of Medical Sciences and Research, Gachibowli, Hyderabad, India, 500032; ³Department of Pulmonary Medicine, Telangana Institute of Medical Sciences and Research, Gachibowli, Hyderabad, India, 500032; ⁴Department of Preventive and Social Medicine, Telangana Institute of Medical Sciences and Research, Gachibowli, Hyderabad, India, 500032; ⁵Department of Family Medicine, Telangana Institute of Medical Sciences and Research, Gachibowli, Hyderabad, India, 500032. *Corresponding author

Email

K. Saritha – E-mail: sarithak.kishore@gmail.com; Phone: +91 9866273410

B.Y. Keerthi – E-mail: keerthiby@gmail.com

Chirali Shah – E-mail: chirali251090@gmail.com

Vimala Thomas – E-mail: vimalath@hotmail.com

Vikram Cheryala – E-mail: vikram.chery@gmail.com

Article Type

Research Article

Date

Received March 1, 2022; Revised April 30, 2022; Accepted April 30, 2022, Published April 30, 2022

It is of interest to assess the immediate and antecedent causes of mortality amongst adult COVID-19 infected patients with or without comorbidities admitted in an exclusive COVID-19 hospital was conducted the between August 2020 to May 2021. The immediate and antecedent causes were collected from the medical certificate of cause of death (MCCD). Remaining data was extracted from the hospital’s record. ICMR protocol was used to grade severity of illness at admission into mild, moderate and severe categories. Clinical status during hospitalisation and most recent radiographic and laboratory data were used to assess disease progression and outcome. This study includes data from 571 people, who died at our centre between August 2020 and May 2021. Patients registered without any co-morbidity were 146 with mean age of 57.53 years; (33/146) were females and (110/46) males. Hypertension (274, 47.99%) was found in a moderately large number of patients followed by diabetes (225, 39.4%) and anaemia (199, 34.6%). Increase in risk of mortality of COVID-19 was found maximum in patients with acute respiratory distress syndrome (72.33%), followed by secondary infections (6.83%). Mortality recorded in this study was mainly in males of older age (50 years and above) with at least one co-morbidity. Anaemia was also prevalent amongst these patients and considered as an independent factor for mortality. Hence, recording of comorbidities and haemoglobin levels may help as a guideline to develop risk stratification and management of patients with COVID-19 to reduce overall mortality.

Keywords

COVID-19 infection, Comorbidities, immediate and antecedent cause of mortality, anaemia

Citation

Keerthi et al. Bioinformation 18(4): 402-410 (2022)

Edited by

P Kangueane

ISSN

0973-2063

Publisher

Biomedical Informatics

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.